1 – 10 of 36
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
- 
                        Mark
        Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer : A study protocol of ARIADNE
    
    - Contribution to journal › Article
 
- 2024
- 
                        Mark
        Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial
    
    - Contribution to journal › Article
 
- 
                        Mark
        Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer
    
    - Contribution to journal › Article
 
- 2023
- 
                        Mark
        Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer : A Swedish retrospective cohort study
    
    - Contribution to journal › Article
 
- 2021
- 
                        Mark
        Variability in Breast Cancer Biomarker Assessment and the Effect on Oncological Treatment Decisions: A Nationwide 5-Year Population-Based Study
    
    - Contribution to journal › Article
 
- 
                        Mark
        Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients with ERBB2-Positive Breast Cancer : A Phase 2 Randomized Clinical Trial
    
    - Contribution to journal › Article
 
- 2020
- 
                        Mark
        Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer : Results from the phase 3 PANTHER trial
    
    - Contribution to journal › Article
 
- 
                        Mark
        MNK2 governs the macrophage antiinflammatory phenotype
    (2020) In Proceedings of the National Academy of Sciences of the United States of America 117(44). p.27556-27565- Contribution to journal › Article
 
- 2019
- 
                        Mark
        Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ
    
    - Contribution to journal › Article
 
- 
                        Mark
        Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease
    
    - Contribution to journal › Article
 
